The agency assessed the safety of Ritalin, which is used to treat attention-deficit hyperactivity disorder (ADHD), and other products containing methylphenidate in response to concerns about its cardiovascular safety.

The review concluded that methylphenidate-containing medicines are safe for the treatment of ADHD in patients over six years old.

However, it said that there is a lack of information on the long-term effects Read more »